financetom
Business
financetom
/
Business
/
National Bank Reviews Rogers Sugar Q4
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
National Bank Reviews Rogers Sugar Q4
Nov 28, 2024 11:04 AM

01:38 PM EST, 11/28/2024 (MT Newswires) -- Rogers Sugar ( RSGUF ) on Thursday reported fourth-quarter revenue of $333 million, beating National's call for $328 million and consensus of $303 million. Adj. EPS of $0.14 was above National's call for $0.13 and the $0.13 consensus forecast.

The company's LEAP project's budget was revised upward by 40-50% to $280-300 million and the project's commissioning will be pushed back ~6 months to H2/26 (was H1/26), National noted.

National sees timelier options elsewhere and is reiterating Sector Perform and $6.25 target on the stock.

Price: 5.98, Change: +0.31, Percent Change: +5.47

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
FTX founder Sam Bankman-Fried is no 'super-villain,' his lawyers say
FTX founder Sam Bankman-Fried is no 'super-villain,' his lawyers say
Mar 20, 2024
NEW YORK (Reuters) - Sam Bankman-Fried is no super-villain and should not spend a medieval 40 to 50 years in prison as prosecutors propose, lawyers for the founder of bankrupt cryptocurrency exchange FTX said in advance of his sentencing next week. In a court filing late on Tuesday, the 32-year-old former billionaire's lawyers said a sentence significantly lower than the...
Labcorp Introduces New Biomarker Test for Alzheimer's Disease
Labcorp Introduces New Biomarker Test for Alzheimer's Disease
Mar 20, 2024
11:21 AM EDT, 03/20/2024 (MT Newswires) -- Labcorp (LH) said Wednesday it has introduced at test to identify the presence or absence of a biomarker in the bloodstream to assist with the diagnosis and monitoring of patients with Alzheimer's disease. The new test was developed to identify patients with the phosphorylated tau 217 biomarker, which has been used by physicians...
Puma Biotechnology Plans to Start Breast Cancer Combination Study in Second Half; Shares Rise
Puma Biotechnology Plans to Start Breast Cancer Combination Study in Second Half; Shares Rise
Mar 20, 2024
11:18 AM EDT, 03/20/2024 (MT Newswires) -- Puma Biotechnology ( PBYI ) said Wednesday that it intends to begin a phase 2 breast cancer study that will evaluate alisertib in combination with endocrine treatment in the second half of 2024. The company said it was notified by the US Food and Drug Administration that its investigational new drug application submission...
Market Chatter: Big Tech to Face EU Election Safeguards
Market Chatter: Big Tech to Face EU Election Safeguards
Mar 20, 2024
11:22 AM EDT, 03/20/2024 (MT Newswires) -- Meta Platforms' ( META ) Facebook, Alphabet's (GOOG, GOOGL) YouTube ( GOOG ), and X are among the major social-media platforms that will be subject to EU fines if they fail to tackle election disinformation, the Financial Times reported Wednesday, citing people familiar with the plans. The guidelines will be adopted by the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved